Exosome therapy is a cell-free regenerative approach that may be discussed after a review of your diagnosis, treatment history, and goals. It is not suitable for every condition or patient.
This page is for information and does not replace advice from your usual specialist. Eligibility, delivery route, and follow-up are determined only after an individual medical review.
Exosome therapy is a cell-free, investigational regenerative approach that may be discussed for some patients after an individual medical review. Suitability is never assumed from a goal or diagnosis alone; it is confirmed case-by-case. It may be discussed with:
Exosome therapy is not an established treatment for any specific disease. The consultation is where evidence limits, uncertainty, and whether an approach is appropriate for you are discussed honestly.
The recommended plan is individualised after records are reviewed; it is not a fixed, one-size-fits-all treatment package.
The team reviews diagnosis, history, imaging or test results, current medication, and the goals you want to discuss.
A clinician considers whether a regenerative approach can be discussed safely, including the delivery route and the need for any further testing.
If appropriate, you receive a written outline of the proposed approach, expected visit schedule, exclusions, and coordination arrangements.
The plan is reconfirmed after an in-person assessment in Istanbul, with remote follow-up arranged after the visit.
Exosomes are signalling particles released by cells. Their potential role in regenerative medicine is an active area of research, and the practical implications for an individual patient should be discussed with the reviewing clinician.
Evidence and outcomes vary by diagnosis, disease stage, delivery approach, and the individual. The consultation is the place to discuss what is known, what remains uncertain, and whether an approach is appropriate for you.
There is no fixed timeline; responses to an investigational approach vary by individual and cannot be predicted. Rather than promising results, the pathway is built around review, defined goals, and monitoring:
Before anything is proposed, the team reviews your diagnosis, history, and current care, and helps translate broad hopes into specific, measurable goals that can actually be followed.
Relevant baseline measures are agreed so that any change — positive, negative, or none — can be assessed objectively rather than assumed.
If an approach is considered appropriate, delivery route and monitoring are confirmed in person in Istanbul. There is no guaranteed onset or magnitude of effect.
Progress is reviewed against the agreed baseline measures, and next steps are discussed alongside your usual specialist. Repeat discussion is considered only where a clear, monitored rationale exists.
While MSC therapy is safe for most patients, certain conditions may be contraindications. Treatment is not suitable in the following situations:
Our medical team conducts a thorough screening process to identify any contraindications before treatment. If stem cell therapy is not appropriate for your situation, we will advise you honestly.
The examples below are illustrative context types — not real patients or promised results. They show the kind of questions a medical review explores and what would be monitored in different situations:
An adult with no diagnosed disease asking about general wellness and recovery, rather than a specific condition.
Review focus: Age-appropriate screening, cardiovascular and cancer risk, and whether a specific, measurable health goal exists that a discussion could reasonably address.
Monitoring: Agreed baseline markers and how they would be re-checked; no biological-age or performance guarantees are made.
Someone with a specialist-managed neurological condition asking whether a cell-free approach could sit alongside their established care.
Review focus: Current diagnosis, disease activity, and treatment plan, and how any discussion would complement — not replace — neurological care.
Monitoring: Defined functional goals tracked with the home neurology team; the approach is investigational and not a substitute for established treatment.
A medically stable person in a recovery phase after an acute illness or procedure, asking about supportive options.
Review focus: Confirmation that the acute phase has passed, fitness for travel, and which recovery goals can be measured alongside ongoing rehabilitation.
Monitoring: Rehabilitation progress and agreed recovery measures reviewed at structured follow-up, coordinated with the home care team.
Treatment at StemCell Longevita is an all-inclusive medical-travel program from your first consultation to your 12-month follow-up:
Your journey begins with a free remote consultation. Our medical team reviews your medical records, imaging, and history to assess suitability — no travel required at this stage.
You receive a written, personalized treatment protocol and plan detailing the recommended cell dosing, delivery route, and expected schedule for your condition.
Our team assists with your travel arrangements. Every package includes VIP airport transfer and a 5-star hotel stay with breakfast included for you and an accompanying family member.
On arrival you undergo an in-person medical evaluation at the JCI-accredited Liv Hospital Ulus in Istanbul before treatment begins.
Treatment is administered over your stay, with a typical total stay of 3-5 days including evaluation, treatment, and monitoring.
After returning home you receive a 12-month telemedicine follow-up program with regular remote check-ins to track your progress.
Exosomes are nano-sized extracellular vesicles (30-150 nanometers) naturally produced by cells, particularly stem cells. They function as cellular messengers, carrying proteins, lipids, RNA, and other bioactive molecules between cells.
Unlike regenerative medicine approach, which involves transplanting living cells, exosome therapy uses these communication vesicles to deliver therapeutic signals without the need for cell transplantation. They are vital for facilitating tissue repair and enhancing cellular health.
At StemCell Longevita, we utilize this advanced therapy to address conditions such as osteoarthritis, chronic pain, musculoskeletal injuries, and neurological disorders.
Exosome therapy involves introducing powerful vesicles into the body to stimulate natural healing processes.
Improve interactions between cells to support recovery and optimize cellular function.
Alleviate inflammatory responses that may impede healing and cause chronic conditions.
Accelerate the repair of damaged tissues including skin, joints, nerves, and organs.
Promote the formation of new blood vessels, improving circulation and oxygen delivery.
While both therapies are integral to regenerative medicine, they have distinct differences:
Potentially faster recovery from injuries and degenerative conditions.
Minimal chances of rejection or adverse side effects since exosomes are cell-free.
Exosomes naturally migrate to areas of injury or inflammation.
Leverages the body's own healing mechanisms for optimal outcomes.
Exosome therapy has shown promising results in treating various medical conditions.
Joint pain, arthritis, tendon injuries, cartilage damage, and sports injuries
Traumatic brain injury, stroke recovery, neurodegenerative diseases
Rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease
Heart disease, post-heart attack recovery, and vascular issues
Skin rejuvenation, hair restoration, and overall anti-aging benefits
Fibromyalgia, chronic back pain, and other persistent pain conditions
Comprehensive evaluation of your medical history, current condition, and treatment goals.
Development of a personalized care plan based on your specific needs.
Exosomes are administered via IV infusion or targeted injections.
Minimal downtime required with monitoring for any reactions.
Regular follow-up appointments to assess progress and determine additional treatments.
